Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer

Journal of Surgical Research

Volumn 171, Issue 1, 2011, Pages 1-5

  Horne, Zachary D ^a   Jack, Robert ^a   Gray, Zachary T ^a   Siegfried, Jill M ^b   Wilson, David O ^a   Yousem, Samuel A ^a   Nason, Katie S ^a   Landreneau, Rodney J ^a   Luketich, James D ^a   Schuchert, Matthew J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

angiolymphatic invasion; non small cell lung cancer; thoracic surgery; tumor infiltrating lymphocytes

Indexed keywords

ADULT; AGED; ANGIOLYMPHATIC INVASION; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 80054696191     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.03.068     Document Type: Article

References (24)

1. M.J. Schuchert, B.L. Pettiford, and S. Keeley Anatomic segmentectomy in the treatment of stage I non-small-cell lung cancer Ann Thorac Surg 84 2007 926
2. W.H. Warren, and L.P. Faber Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of intrathoracic recurrence J Thorac Cardiovasc Surg 107 1994 1087
3. Ö Birim, A.P. Kappetein, and J.M. Takkenberg Survival after pathological stage IA non-small-cell lung cancer: Tumor size matters Ann Thorac Surg 79 2005 1137
4. A.K. Eerola, Y. Soini, and P. Paakko A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma Clin Cancer Res 6 2000 1875
5. S. Kondratiev, E. Sabo, and E. Yakirevich Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma Clin Cancer Res 10 2004 4450
6. T. Oshikiri, M. Miyamoto, and T. Shichinohe Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response J Surg Oncol 84 2003 224
7. K. Schumacher, W. Haensch, and C. Roefzaad Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas Cancer Res 61 2001 3932
8. P. Sharma, Y. Shen, and S. Wen CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle invasive urothelial carcinoma Proc Natl Acad Sci USA 104 2007 3967
9. S. Staibano, M. Mascolo, and F. Tranfa Tumor infiltrating lymphocytes in uveal melanoma: A link with clinical behavior? Int J Immunopathol Pharmacol 19 2006 171 179
10. B.E. Wahlin, B. Sander, B. Christensson, and E. Kimby CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma Clin Cancer Res 13 2007 388
11. Y. Naito, K. Saito, and K. Shiiba CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 1998 3491
12. M.P. Pelletier, M.D. Edwardes, and R.P. Michel Prognostic markers in resectable non-small-cell lung cancer: A multivariate analysis Can J Surg 44 2001 180
13. K. Hiraoka, M. Miyamoto, and Y. Cho Concurrent infiltration by CD8+ T cells and CD4+ Tcells is a favorable prognostic factor in non-small-cell lung carcinoma Br J Cancer 94 2006 275
14. H. Nakamura, H. Saji, and A. Ogata Immunologic parameters as significant prognostic factors in lung cancer Lung Cancer 37 2002 161
15. R.P. Peterson, M.J. Campa, and J. Sperlazza Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients Cancer 107 2006 2866
16. X. Chen, J.J. Subleski, and H. Kopf Cutting edge: Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: Applicability to tumor-infiltrating T regulatory cells J Immunol 180 2008 6467
17. O. Kawai, G. Ishii, and K. Kubota Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV non-small-cell lung cancer Cancer 113 2008 1378
18. P. Carrega, B. Morandi, and R. Costa Natural killer cells infiltrating human non-small-cell lung cancer are enriched in CD56-bright CD16- cells and display an impaired capacity to kill tumor cells Cancer 112 2008 863
19. K.I. Al-Shibli, T. Donnem, and S. Al-Saad Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer Clin Cancer Res 14 2008 5220
20. X. Zhuang, X. Xia, and C. Wang A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis Appl Immunohistochem Mol Morphol 18 2010 24
21. E. Ruffini, S. Asioli, and P.L. Filosso Clinical significance of tumor-infiltration lymphocytes in lung neoplasms J A Thorac Sur 87 2008 365
22. H. Han, J.F. Silverman, and T.S. Santucci Vascular endothelial growth factor expression in stage I non-small-cell lung cancer correlates with neoangiogenesis and a poor prognosis Ann Surg Oncol 8 2001 72
23. C.P. Hsu, J.Y. Hsia, and G.C. Chang Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small-cell lung cancer: A heterogeneous disease J Thorac Cardiovasc Surg 138 2009 426
24. Y.M. El-Gohary, J.F. Silverman, and P.R. Olson Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma Am J Clin Pathol 127 2007 572